Call for Abstract

2nd International Conference and Exhibition on Pharmaceutical Development and Technology, will be organized around the theme “Future trends in Development of Pharmaceuticals”

Pharma Tech 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharma Tech 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1 Physical pharmacy
  • Track 1-2 Pro-drug design
  • Track 1-3 Biologics
  • Track 1-4 Pharmaceutical Analysis
  • Track 1-5Pharmaceutical Packaging
  • Track 1-6 Drug Pharmacokinetics
  • Track 1-7 Quality control
  • Track 1-8Good Manufacturing Practices
  • Track 2-1 Rational drug design
  • Track 2-2 Biotargets
  • Track 2-3 Computer Aided drug Design
  • Track 2-4 Bioweapons
  • Track 2-5Tumour Targeting
  • Track 2-6 Mitochondrial Targeting
  • Track 3-1 Small Drug Molecules
  • Track 3-2Development of Vaccines
  • Track 3-3Gene specific Drugs
  • Track 3-4Proteins and Peptides
  • Track 4-1 Biomaterials
  • Track 4-2Exfoliated Vermiculite
  • Track 4-3 Polymers
  • Track 4-4 Graphene
  • Track 4-5Quantum Dots
  • Track 4-6Microcapsules
  • Track 4-7Hybrid materials
  • Track 5-1 Pharmaceutical Excipients
  • Track 5-2 Pharmaceutical Product Development
  • Track 5-3 Types of Drug Formulation
  • Track 5-4 Ophthalmic Formulation
  • Track 5-5 Paediatric Formulation Development
  • Track 5-6Medication Formulation
  • Track 5-7Topical Formulations
  • Track 6-1 Microarray Technology
  • Track 6-2 Industrial Biotechnology
  • Track 6-3 Bioformulations
  • Track 6-4Vaccines and Antibiotics
  • Track 6-5Nucleic Acid Products
  • Track 6-6Biologically inspired Pharmaceutics
  • Track 7-1Biomedical Nanotechnology
  • Track 7-2 Nanotechnology and Nanomedicine
  • Track 7-3Nano Drug Delivery
  • Track 7-4 Nano Liposomes
  • Track 7-5 Nano Pharmaceuticals
  • Track 7-6 Applied Nanotechnology
  • Track 8-1 Technology Transfer
  • Track 8-2 Pharmaceutical Technology Assessment
  • Track 8-3 Quality assurance
  • Track 8-4 Bioinformatics and Computational Biology
  • Track 8-5 Pharmacological Technology advances
  • Track 8-6Pharmaceutical Packaging and labelling
  • Track 9-1 Active Pharmaceutical Ingredient synthesis
  • Track 9-2Processing and Engineering
  • Track 9-3Medication management
  • Track 9-4 Bioprocessing
  • Track 9-5Molecular isotopic engineering
  • Track 9-6Supply chain safety
  • Track 10-1 Pre formulation
  • Track 10-2 Freeze Drying techniques
  • Track 10-3Pharmaceutical sales
  • Track 10-4Pharmaceutical Process Equipment
  • Track 10-5GMP International standards
  • Track 10-6 Pharmaceutical validation

With Drug Delivery Technology the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. To enhance their therapeutic effects and reduce the related side effects, active drug molecules should selectively accumulate in the disease area for a prolonged period with high controllability. In comparison to the conventional DDSs, the smart controlled DDSs can effectively reduce the dosage frequency, while maintaining the drug concentration in targeted organs/tissues for a longer period of time. In this sense, the controlled DDSs provide broad insights and fascinating properties for decreasing drug concentration fluctuation, reducing drug toxicities and improving therapeutic efficacy.

  • Track 12-1Biomedical Instrumentation Measurements
  • Track 12-2Instrumentation for the Medical Use of Radioisotopes
  • Track 12-3Respiratory Therapy Equipment
  • Track 12-4Elastography and Ultrasonography
  • Track 12-5Thermography and Tomography
  • Track 12-6Positron-Emission Tomographic (PET) Scanning
  • Track 12-7Computed Tomographic Scanning (CT Scanning)
  • Track 12-8Ophthalmic and ENT Instruments
  • Track 12-9Pacemakers and Defibrillators
  • Track 12-10Instrumentation for the Experimental Analysis of Behaviour
  • Track 12-11Instrumentation for Psychophysiological Measurements
  • Track 12-123D printing of medical devices
  • Track 12-13Forensic Devices
  • Track 13-1Regulatory & Pharmacovigilance
  • Track 13-2Regulatory compliance
  • Track 13-3Regulatory requirements of pharmaceutical products
  • Track 13-4Marketing Authorizations
  • Track 13-5Clinical Affairs & Regulatory Strategies
  • Track 13-6Intellectual Property Rights